As of 2026-01-07, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (10.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -247.4%.
The range of the Relative Valuation is (7.76) - (13.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.6x | 12.4x |
| Forward P/E multiples | 9.1x - 15.9x | 12.5x |
| Fair Price | (7.76) - (13.25) | (10.54) |
| Upside | -208.5% - -285.4% | -247.4% |
| Date | P/E |